» Articles » PMID: 40065168

Selection for Somatic Escape Variants in SERPINA1 in the Liver of Patients with Alpha-1 Antitrypsin Deficiency

Overview
Journal Nat Genet
Specialty Genetics
Date 2025 Mar 11
PMID 40065168
Authors
Affiliations
Soon will be listed here.
Abstract

Somatic variants accumulate in non-malignant tissues with age. Functional variants, leading to clonal advantage of hepatocytes, accumulate in the liver of patients with acquired chronic liver disease (CLD). Whether somatic variants are common to CLD from differing etiologies is unknown. We analyzed liver somatic variants in patients with genetic CLD from alpha-1 antitrypsin (A1AT) deficiency or hemochromatosis. We show that somatic variants in SERPINA1, the gene encoding A1AT, are strongly selected for in A1AT deficiency, with evidence of convergent evolution. Acquired SERPINA1 variants are clustered at the carboxyl terminus of A1AT, leading to truncation. In vitro and in vivo, C-terminal truncation variants reduce disease-associated Z-A1AT polymer accumulation and disruption of the endoplasmic reticulum, supporting the C-terminal domain swap mechanism. Therefore, somatic escape variants from a deleterious germline variant are selected for in A1AT deficiency, suggesting that functional somatic variants are disease-specific in CLD and point to disease-associated mechanisms.

References
1.
Huang D, Terrault N, Tacke F, Gluud L, Arrese M, Bugianesi E . Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023; 20(6):388-398. PMC: 10043867. DOI: 10.1038/s41575-023-00759-2. View

2.
BERG N, Eriksson S . Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972; 287(25):1264-7. DOI: 10.1056/NEJM197212212872502. View

3.
Carrell R, Lomas D . Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med. 2002; 346(1):45-53. DOI: 10.1056/NEJMra010772. View

4.
Ng S, Rouhani F, Brunner S, Brzozowska N, Aitken S, Yang M . Convergent somatic mutations in metabolism genes in chronic liver disease. Nature. 2021; 598(7881):473-478. DOI: 10.1038/s41586-021-03974-6. View

5.
Wang Z, Zhu S, Jia Y, Wang Y, Kubota N, Fujiwara N . Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease. Cell. 2023; 186(9):1968-1984.e20. PMC: 10321862. DOI: 10.1016/j.cell.2023.03.014. View